Medicine & Life Sciences
Vaccines
100%
Influenza Vaccines
58%
Vaccination
52%
Infections
48%
Enterotoxigenic Escherichia coli
41%
Shigella
41%
Attenuated Vaccines
34%
Human Influenza
30%
Bacillary Dysentery
28%
Diarrhea
27%
Shigella Vaccines
27%
Shigella flexneri
27%
Pandemics
25%
Coronavirus
25%
Placebos
24%
Chagas Disease
22%
Antibody Formation
21%
Campylobacter Infections
20%
Campylobacter jejuni
20%
Safety
19%
Dengue Vaccines
18%
Antibodies
16%
Hemagglutination
16%
Cutaneous Leishmaniasis
15%
Latent Class Analysis
13%
Coinfection
13%
Antibody Affinity
13%
miltefosine
13%
GS-5734
13%
H7N3 Subtype Influenza A Virus
12%
Shigella sonnei
12%
Dengue
12%
Child
12%
Serum
12%
H2N2 Subtype Influenza A Virus
12%
Immunization
12%
Hemagglutinins
11%
Thrombocytopenia
11%
Immunoglobulin G
11%
colonization factor antigens
11%
Rifaximin
11%
India
10%
Viruses
10%
Immunity
10%
Young Adult
9%
Antigens
9%
Confidence Intervals
9%
Dengue Virus
9%
Immunoglobulin A
9%
Orthomyxoviridae
9%
Agriculture & Biology
influenza vaccines
45%
vaccines
31%
live vaccines
17%
dosage
10%
pandemic
9%
neoplasm progression
9%
Human immunodeficiency virus
8%
Shigella
8%
cutaneous leishmaniasis
8%
interleukin-4
7%
hemagglutinins
7%
Plasmodium falciparum
7%
immunogenicity
7%
interleukin-10
7%
Mycobacterium
6%
mixed infection
6%
lymph nodes
6%
malaria
6%
B-lymphocytes
6%
macrophages
5%
infection
5%